van Rosmalen J - Search Results

1

Incorporating historical control information in ANCOVA models using the meta-analytic-predictive approach.

Qi H, Rizopoulos D, van Rosmalen J. Qi H, et al. Among authors: van rosmalen j. Res Synth Methods. 2022 Nov;13(6):681-696. doi: 10.1002/jrsm.1561. Epub 2022 Apr 26. Res Synth Methods. 2022. PMID: 35439840 Free PMC article.

2

Prevalence and determinants of declining versus stable hemoglobin levels in whole blood donors.

Nasserinejad K, van Rosmalen J, van den Hurk K, Baart M, Hoekstra T, Rizopoulos D, Lesaffre E, de Kort W. Nasserinejad K, et al. Among authors: van rosmalen j, van den hurk k. Transfusion. 2015 Aug;55(8):1955-63. doi: 10.1111/trf.13066. Epub 2015 Mar 10. Transfusion. 2015. PMID: 25753152

3

Personalized screening intervals for biomarkers using joint models for longitudinal and survival data.

Rizopoulos D, Taylor JM, Van Rosmalen J, Steyerberg EW, Takkenberg JJ. Rizopoulos D, et al. Among authors: van rosmalen j. Biostatistics. 2016 Jan;17(1):149-64. doi: 10.1093/biostatistics/kxv031. Epub 2015 Aug 28. Biostatistics. 2016. PMID: 26319700 Free PMC article.

4

Prediction of hemoglobin in blood donors using a latent class mixed-effects transition model.

Nasserinejad K, van Rosmalen J, de Kort W, Rizopoulos D, Lesaffre E. Nasserinejad K, et al. Among authors: van rosmalen j. Stat Med. 2016 Feb 20;35(4):581-94. doi: 10.1002/sim.6759. Epub 2015 Oct 14. Stat Med. 2016. PMID: 26467774

5

Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior.

Qi H, Rizopoulos D, Lesaffre E, van Rosmalen J. Qi H, et al. Among authors: van rosmalen j. Pharm Stat. 2022 Sep;21(5):818-834. doi: 10.1002/pst.2195. Epub 2022 Feb 6. Pharm Stat. 2022. PMID: 35128780 Free PMC article.

6

Joint Modeling of Repeated Measurements of Different Biomarkers Predicts Mortality in COVID-19 Patients in the Intensive Care Unit.

Tong-Minh K, van der Does Y, van Rosmalen J, Ramakers C, Gommers D, van Gorp E, Rizopoulos D, Endeman H. Tong-Minh K, et al. Among authors: van rosmalen j, van der does y, van gorp e. Biomark Insights. 2022 Jul 14;17:11772719221112370. doi: 10.1177/11772719221112370. eCollection 2022. Biomark Insights. 2022. PMID: 35859926 Free PMC article.

7

Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.

Qi H, Rizopoulos D, van Rosmalen J. Qi H, et al. Among authors: van rosmalen j. Res Synth Methods. 2023 May;14(3):396-413. doi: 10.1002/jrsm.1618. Epub 2023 Jan 14. Res Synth Methods. 2023. PMID: 36625478

8

Including historical data in the analysis of clinical trials: Is it worth the effort?

van Rosmalen J, Dejardin D, van Norden Y, Löwenberg B, Lesaffre E. van Rosmalen J, et al. Among authors: van norden y. Stat Methods Med Res. 2018 Oct;27(10):3167-3182. doi: 10.1177/0962280217694506. Epub 2017 Feb 21. Stat Methods Med Res. 2018. PMID: 28322129 Free PMC article.

9

Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects.

Dejardin D, Delmar P, Warne C, Patel K, van Rosmalen J, Lesaffre E. Dejardin D, et al. Among authors: van rosmalen j. Pharm Stat. 2018 Mar;17(2):169-181. doi: 10.1002/pst.1843. Epub 2017 Dec 28. Pharm Stat. 2018. PMID: 29282862

10

Modified power prior with multiple historical trials for binary endpoints.

Banbeta A, van Rosmalen J, Dejardin D, Lesaffre E. Banbeta A, et al. Among authors: van rosmalen j. Stat Med. 2019 Mar 30;38(7):1147-1169. doi: 10.1002/sim.8019. Epub 2018 Oct 25. Stat Med. 2019. PMID: 30360016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters